How can patients help shape the future of scientific innovation? What's the vital role of the patient's voice in developing life-changing medicines? In this captivating episode, fresh off her thought-provoking appearance at the 9th Annual BioHealth Capital Region Forum, Dr. Theresa Podrebarac takes us on a journey through the dynamic landscape of autoimmune medicine.
Dr. Podrebarac is a renowned physician scientist with a wealth of expertise in the biotech industry. As the Senior Vice President of Clinical Development at Horizon Therapeutics, she's at the forefront of bringing hope to patients with rare, autoimmune, and severe inflammatory diseases. Join us as we explore pivotal questions:
Don't miss this enlightening conversation that delves into the nexus of science, patient advocacy, and innovation. Tune in now and become part of the future where patients' voices are not just heard but lead the way in shaping a brighter tomorrow. Available on all major podcasting platforms.
Theresa Podrebarac, M.D., M.Sc., is a physician scientist with extensive development expertise in the biotech industry. At Horizon Therapeutics, Dr. Podrebarac leads the clinical development function dedicated to bringing medicines for rare, autoimmune and severe inflammatory diseases to patients. Prior to Horizon, Dr. Podrebarac served as chief medical officer at two biotech companies focusing on rare diseases. She was also vice president, immunology clinical development at AbbVie where she helped develop approved therapies for psoriasis and rheumatoid arthritis. At Biogen, she championed the development of tools and techniques for early clinical proof of concept in diseases including scleroderma and lupus skin disease.
Dr. Podrebarac holds a master of science in immunology from the University of Ottawa and a medical doctorate degree from Western University. She completed a postdoctoral fellowship in immunology at Harvard University.
Advancing Biotech: Insights from Michael J. Tarlov, Chief of the Biomolecular Measurement Division at NIST
Building Baltimore's Future: Kory Bailey and the UpSurge Vision
John Sackett - Execuitve Vice President & COO, Adventist Healthcare
Empowering Change: Lance Kawaguchi's Journey with the Cure Brain Cancer Foundation
Nanochon's Orthopedic Revolution: A New Era in Cartilage Restoration
Advancing Hope: Solaxa’s Quest to Treat Cerebellar Ataxias
Navigating the AI Wave: Dr. Juergen Klenk Explores AI's Reality in the BioHealth Industry
Pioneering Solutions: Dr. Nehal Mehta's Quest to Combat Chronic Diseases at Mobius Scientific
Investing in BioHealth: Blackbird Labs Vision with CEO Matt Tremblay
Breaking Barriers in Enteral Nutrition: Luminoah's Innovative MedTech with Neal Piper
Driving Cancer Research Innovation: A Conversation with Michael Weingarten, Director, SBIR Development Center at the National Cancer Institute (NCI)
Unlocking the Future of Stem Cell Research with MSCRF: A Conversation with Ruchika Nijhara, PhD, Executive Director of Maryland Stem Cell Research Fund (MSCRF)
Revolutionizing Autoimmune Medicine: MyMD Pharmaceuticals Innovative Therapies
Pioneering Biotech Advancements: A Conversation with Rachel King, CEO of BIO
Nurturing Tomorrow's STEM Leaders: A Conversation with Dr. Judy Staveley, Biotechnologist and STEM Advocate
BioTalk Discusses Breaking Frontiers in Immunotherapy: A Conversation with Bill Enright, CEO and Board Director at Vaccitech
How the BioHealth Capital Region Became a Top 3 BioPharma Cluster: Insights from Alex Philippidis, Senior Business Editor at Genetic Engineering & Biotechnology News
Navigating Growth and Collaboration in Life Sciences: A Conversation with Brad L. Stewart, SVP of Business Development, MCEDC
Building Better Medicine, and Transformative Partnerships: Insights from Joy Polefrone, Ph.D. on BioTalk
Create your
podcast in
minutes
It is Free
The emPOWERed Half Hour
NABOR® TALKS
U.S Property Podcast
Aligned Money Show
The Ramsey Show
Planet Money